Physicians do not treat averages - But therapy responders!;Ärzte behandeln keine Mittelwerte - sondern Therapieresponder!

Schmerz

Volumn 26, Issue 1, 2012, Pages 5-7

  Maier, C ^a   Baron, R ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; PAIN; PHYSICIAN;

ANALGESICS; BIAS (EPIDEMIOLOGY); GERMANY; GUIDELINE ADHERENCE; HUMANS; INSURANCE COVERAGE; INSURANCE, PHARMACEUTICAL SERVICES; NATIONAL HEALTH PROGRAMS; NUMBERS NEEDED TO TREAT; PAIN; PAIN MEASUREMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84857720397     PISSN: 0932433X     EISSN: 14322129     Source Type: Journal    
DOI: 10.1007/s00482-011-1134-0     Document Type: Editorial

References (23)

1. Baron R, Binder A, Wasner G (2010) Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 9:807-819
2. Dworkin RH, O'Connor AB, Audette J, et al.. (2010) Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85(3 Suppl):S3-S14
3. Dworkin RH, Turk DC, Basch E, et al. (2011) Considerations for extrapolating evidence of acute and chronic pain analgesic efficacy. Pain 152:1705-1708
4. Dworkin RH, Turk DC, Wyrwich KW, et al. (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9:105-21 (Pubitemid 351147828)
5. Farrar JT, Dworkin RH, Max MB (2006) Use of the cumulative proportion of responders analysis graph to present pain data over a range of cut-off points: making clinical trial data more understandable. J Pain Symptom Manage 31:369-77
6. Fields HL, Rowbotham M, Baron R (1998) Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 5:209-227 (Pubitemid 28519152)
7. Finnerup NB, Sindrup SH, Jensen TS (2010) The evidence for pharmacological treatment of neuropathic pain. Pain 150:573-81. PMID 20705215
8. Hansson PT, Attal N, Baron R, Cruccu G (2009) Toward a definition of pharmacoresistant neuropathic pain. Eur J Pain 13:439-440
9. http://www.imi.europa.eu/sites/default/files/uploads/documents/ 1stCallFactSheets.pdf
10. http://www.neuro.med.tu-muenchen.de/dfns/
11. Kalso E, Simpson KH, Slappendel R, et al. (2007) Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine. BMC Med 5:39
12. Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen (LONTS). www.awmf.org/leitlinien/detail/ll/041-003.html. (Auszug: Dezember 2011)
13. Maier C, Baron R, Tölle TR, et al. (2010) Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 150:439-450
14. Maier C, Hildebrandt J, Klinger R, et al. (2009) Morphine responsiveness efficacy and tolerability in patients with chronic non-tumor associated pain - results of a double-blind placebo-controlled trial (MONTAS). Pain 97:223-233
15. Maier C, Schaub C, Willweber-Strumpf A, Zenz M (2005) Langfristige Effekte von Opioiden bei Patienten mit chronischen nicht-tumorbedingten Schmerzen. Ergebnisse einer Nachuntersuchung 5 Jahre nach Ersteinstellung. Schmerz 19:410-417 (Pubitemid 41386426)
16. McQuay HJ, Carroll D, Moore RA (1996) Variation in the placebo effect in randomised controlled trials of analgesics: all is as blind as it seems. Pain 64:331-335 (Pubitemid 26132445)
17. Moore RA, Moore OA, Derry S, et al. (2010) Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice. Ann Rheum Dis 69:374-9
18. Simpson DM, Schifitto G, Clifford DB, et al. (2010) Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 74:413-420
19. Stamer UM, Zhang L, Stüber F (2010) Personalized therapy in pain management: where do we stand? Pharmacogenomics 11:843-864
20. Straube S, Derry S, Moore RA, et al. (2010) Pregabalin in fibromyalgia - responder analysis from individual patient data. BMC Musculoskelet Disord 11:150
21. Sultan A, Gaskell H, Derry S, Moore RA (2008) Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol 8:29. PMID 18673529; PMCID PMC2529342
22. Vase L, Noerskov KN, Petersen GL, Price DD (2011) Patients' direct experiences as central elements of placebo analgesia. Philos Trans R Soc Lond B Biol Sci 366:1913-1921
23. Woolf CJ, Mannion RJ (1999) Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353:1959-1964